ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Gainers
ALL ORDINARIES finishes higher Friday: 8 shares you missed
Share Fallers
Why the ResMed share price is tumbling after a A$2.5 billion acquisition spree
Share Fallers
Why AMP, API, Netwealth, and ResMed shares are ending the week in the red
Share Market News
ASX 200 lunch time report: Afterpay, Iluka, & Nine shares higher
Share Fallers
ResMed share price expected to sink lower after revenue and earnings miss
Share Market News
5 things to watch on the ASX 200 on Friday
Share Market News
Top brokers name 3 ASX shares to sell today
⏸️ ASX Shares
The 5 best blue chip ASX shares to buy this week
Share Market News
5 founder led companies to buy in 2019
52-Week Highs
Why the ResMed Inc. share price just hit another record high
Growth Shares
Where to invest $25,000 in buy and hold ASX shares
Growth Shares
Where to invest $5,000 in the ASX in January
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
